The cancer megafund: mathematical modeling needed to gauge risk
NATURE BIOTECHNOLOGY（2013）
Abstract
To the Editor: As a CEO and former investment banker specializing in securitization, I noted with interest the paper by Andrew Lo and colleagues1 proposing the application of securitization techniques to fund biopharmaceutical R&D. Such an approach promises to both enlarge the investor base willing to back breakthrough research and create… Download references
MoreTranslated text
Key words
Drug development,Pharmacoeconomics,Life Sciences,general,Biotechnology,Biomedicine,Agriculture,Biomedical Engineering/Biotechnology,Bioinformatics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined